Komori
General Meetings of Shareholders4549EIKEN CHEMICAL CO.,LTD.Pharmaceuticals

Notice of Convocation of the 88th Annual General Meeting of Shareholders

At the 88th Annual General Meeting of Shareholders, the Company will submit for consideration a company proposal to elect 10 directors and a shareholder proposal to elect 2 additional directors. The company proposal includes 1 new candidate, and the Board of Directors opposes the shareholder proposal.

Worth reading
79Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
10
people (number of director candidates proposed by the company)
Wording
Conditional
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual, 88th fiscal period
2026
Jun 23
Date and time(Tuesday), 10:00 a.m. (registration opens at 9:00 a.m.)22 days from this disclosure to the meeting
Matters for resolution2 items
  1. Election of 10 directors

  2. Election of 2 directors

Shareholder Proposal

Proposal by Nippon Active Value Fund plc to elect 2 directors. The candidates are Nishida Masumi (西田真澄) and Mizuochi Kazutaka (水落一隆). The Board of Directors opposes the proposal.

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nomineeCompany proposal: 10 candidates (1 new and 7 outside directors). Shareholder proposal: 2 candidates (new and outside directors).
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual, 88th fiscal period
Date and time23 June 2026 (Tuesday), 10:00 a.m. (registration opens at 9:00 a.m.)
Matters for resolutionProposal No. 1: Election of 10 directors, Proposal No. 2: Election of 2 directors
Shareholder ProposalProposal by Nippon Active Value Fund plc to elect 2 directors. The candidates are Nishida Masumi (西田真澄) and Mizuochi Kazutaka (水落一隆). The Board of Directors opposes the proposal.
Director nomineeCompany proposal: 10 candidates (1 new and 7 outside directors). Shareholder proposal: 2 candidates (new and outside directors).
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company proposal is intended to elect candidates who meet the nomination criteria and to strengthen and enhance the monitoring and oversight of business execution by ensuring that outside directors constitute a majority of the Board. The reasons given for opposing the shareholder proposal are concerns regarding the candidates’ independence, the risk that the interests of general shareholders could be adversely affected, and the view that a Board composed of the company’s proposed candidates would be optimal for implementing the new management plan and maximizing corporate and shareholder value.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 88th Annual General Meeting of Shareholders | EIKEN CHEMICAL CO.,LTD. (4549) timely disclosure | Komori